rbet v1-fv
Allergenexperimental
Clinical trial activity
6 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2006 (NCT00396149)
Timeline
Indications
Mechanism of action
- Tree pollenImmunity, desensitized
Tree pollen immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rbet v1-fv
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01449786 | Phase 2 | Mar 14, 2012 | Austrian Science Fund (FWF), University of Vienna |
| NCT01490411 | Phase 2 | Oct 1, 2010 | Allergopharma GmbH & Co. KG |
| NCT00901914 | Phase 2 | Oct 1, 2008 | Aptuit Inc., IQVIA, Stallergenes, University of Gothenburg |
| NCT00841516 | Phase 2 | Dec 1, 2007 | Allergopharma GmbH & Co. KG, University of Applied Sciences Würzburg-Schweinfurt |
| NCT00889460 | Phase 1 | Nov 1, 2007 | IQVIA, Stallergenes, University of Copenhagen |
| NCT00396149 | Phase 1 | Nov 1, 2006 | IQVIA, Stallergenes, University of Copenhagen |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| IQVIA | For profit | 3 | 0 | 2 | 2006 |
| Stallergenes | For profit | 3 | 3 | 2 | 2006 |
| Allergopharma GmbH & Co. KG | For profit | 2 | 2 | 1 | 2007 |
| University of Copenhagen | Academic/Hospital | 2 | 0 | 1 | 2006 |
| Aptuit Inc. | For profit | 1 | 0 | 1 | 2008 |
| Austrian Science Fund (FWF) | Government | 1 | 0 | 1 | 2012 |
| University of Applied Sciences Würzburg-Schweinfurt | Academic/Hospital | 1 | 0 | 1 | 2007 |
| University of Gothenburg | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of Vienna | Academic/Hospital | 1 | 1 | 1 | 2012 |
9 organizations
Page 1 / 1